A patient of Parkinsonism, Mr. Ghai noticed that the therapeutic effect of levodopa decreased when he was given another drug by his physician but no interaction was seen when he switched over to levodopa-carbidopa combination. The possible drug prescribed by his physician can be:
**Core Concept**
Parkinsonism is a neurological disorder characterized by the loss of dopamine-producing neurons in the substantia nigra, leading to motor symptoms such as tremors, bradykinesia, and rigidity. Levodopa, a precursor to dopamine, is a primary treatment for Parkinson's disease. However, its effectiveness can be influenced by various factors, including drug interactions.
**Why the Correct Answer is Right**
The therapeutic effect of levodopa decreased when Mr. Ghai was given another drug by his physician, suggesting a drug interaction. This interaction is likely due to the inhibition of aromatic L-amino acid decarboxylase (AADC), an enzyme responsible for converting levodopa to dopamine. By inhibiting AADC, the other drug reduces the availability of dopamine in the synaptic cleft, leading to decreased therapeutic effect. Carbidopa, on the other hand, is a peripheral AADC inhibitor that does not cross the blood-brain barrier, thus preventing the peripheral conversion of levodopa to dopamine and increasing its availability in the brain.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, but a possible answer could be a drug that inhibits the dopamine transporter (e.g., reserpine), which would not decrease levodopa's therapeutic effect.
**Option B:** This option is not provided, but a possible answer could be a drug that is a central AADC inhibitor, which would not prevent the interaction with levodopa.
**Option C:** This option is not provided, but a possible answer could be a drug that is a dopamine receptor antagonist (e.g., haloperidol), which would not decrease levodopa's therapeutic effect.
**Clinical Pearl / High-Yield Fact**
To maximize the therapeutic effect of levodopa in Parkinson's disease, it is essential to consider the potential for drug interactions, particularly those that inhibit AADC. The combination of levodopa and carbidopa is a classic example of a pharmacological strategy to prevent such interactions and optimize treatment outcomes.
**Correct Answer:** D.